Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01951378 · ClinicalTrials.gov registry record · Phase 4
Comparison of Nebulizers in ED in Pediatric Asthma Patients
A Phase 4 study, sponsored by Seton Healthcare Family.
- Terminated
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01951378 is a Phase 4 study that was terminated before completion, run by Seton Healthcare Family. The registered enrollment target is 40 participants.
The verdict
NCT01951378, a Phase 4 study, was terminated before completion, sponsored by Seton Healthcare Family.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The primary objective will be, in an open-label randomized trial, a comparison of emergency department (ED) length of stay (LOS) between children experiencing acute asthma treated with two different nebulizers. Secondary outcomes will include admission rates, hospital LOS, need for additional therapies, transfers to a higher level of care, side-effects, and unscheduled return visits
Interventions
- DRUG Albuterol
- DEVICE Hudson RCI® nebulizer
- DEVICE NebuTech® HDN® nebulizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01951378
The ClinicalTrials.gov registry entry for NCT01951378 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seton Healthcare Family, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Albuterol is the first listed.
NCT01951378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01951378 about?
NCT01951378 is a clinical study titled "Comparison of Nebulizers in ED in Pediatric Asthma Patients". The primary objective will be, in an open-label randomized trial, a comparison of emergency department (ED) length of stay (LOS) between children experiencing acute asthma treated with two different nebulizers. Secondary outcomes will include admission rates, hospital LOS, need for additional therap...
What is the current status of trial NCT01951378?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2013-09. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01951378?
The interventions under investigation include: Albuterol (DRUG), Hudson RCI® nebulizer (DEVICE), NebuTech® HDN® nebulizer (DEVICE).
Who is sponsoring clinical trial NCT01951378?
This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.